An expert writes about his experience as a sarcoma medical oncologist and how the field may progress with several therapies in the pipeline. As a sarcoma medical oncologist, the No. 1 question I am ...

The global Kaposi’s Sarcoma market is expanding due to the HIV/AIDS prevalence, improved oncology infrastructure, and advancements in targeted and immunotherapeutic drugs. Kaposi’s Sarcoma, a tumor ...

The field of sarcoma study is getting more specific, with clinical investigations drilling down to more specific subtypes of soft tissue sarcoma for better targeted therapies. Our discussion with ...

The FDA's orphan drug designation supports LP-284's development for soft tissue sarcomas, addressing significant unmet needs in this adult patient population. The FDA granted orphan drug designation ...

Community members packed a local pickleball venue to raise money for a West Fargo man who is battling a rare form of cancer ...

Success rates for drug development in solid tumors remain the lowest of the many therapeutics areas in medicine. Recent advances in drug discovery and development have transformed available therapies ...

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leading AI-based molecular and immune profiling solutions provider, and the Sarcoma Oncology Center, announced a collaboration to expedite the ...

Soft tissue sarcomas are rare, aggressive cancers with complex treatment needs and high mortality, especially in metastatic cases. The study found no significant difference in median TTI between MDC ...

Ewing sarcoma is a malignant type of bone tumor, meaning it is a form of cancer that spreads. According to a 2024 review, Ewing sarcoma is the second most common primary cancerous bone tumor. It ...

Kaposi sarcoma of the eyelid is a rare type of cancer that can grow from the cells lining the lymph vessels or blood vessels in the eyelid. In most cases, Kaposi sarcoma tumors appear on the skin, ...